55P EGFR variant allele frequency (VAF) impacts on metastatic NSCLC patients outcome during first-line osimertinib by Riva, S.T., Ogliari, F.R., Cangi, M.G., Bucci, G., Foggetti, G., Ferrara, R., Pecciarini, L., Oresti, S., Viganò, M.G., Damiano, G., Gandolfi, G., Guzzeloni, V., Valci, S., Ferrara, M., Nuccio, A., Venanzi, F.M., Pilotto, S., Bulotta, A., Milella, M., Reni, M.

Get full text

P1.01-59 Expanding Access to Large-Scale Genomic Mutational Analyses for Patients with Advanced NSCLC in Italy by Gregorc, V., Lazzari, C., Guida, A., Bucci, G., Graziano, P., Cangi, M.G., Frigè, G., Rossi, A., Ceol, A., Sardina, D., Milella, M., Pallocca, M., Vigneri, P., Fancello, L., Buglioni, S., Motta, G., Biagini, T., Rijavec, E., Bonfiglio, S., Delmonte, A., Toschi, L., Banna, G., Galetta, D., Bearz, A., Tartarone, A., Verderame, F., Daidone, M., Fanciulli, M., Ciliberto, G., Pelicci, P.G., De Maria, R., Mazzarella, L.

Get full text

Syndecan-1 (CD138) expression in human breast carcinoma is associated with an aggressive phenotype and appears related to a poor prognosis and low response to adjuvant chemotherapy by Galligioni, E., Barbareschi, M., Aldovini, D., Maisonneuuve, P., Cangi, M.G., Pecciarini, L., Caffo, O., Arcuri, C., Dalla Palma, P., Doglioni, C.

Get full text